pSivida Corp.
(NASDAQ : PSDV)

( )
PSDV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.25%80.150.9%$597.90m
CELGCelgene Corporation
0.58%137.501.1%$551.19m
AMGNAmgen Inc.
0.00%181.901.1%$427.51m
BIIBBiogen Inc.
2.07%342.631.2%$376.08m
REGNRegeneron Pharmaceuticals, Inc.
0.00%445.682.7%$321.88m
ALNYAlnylam Pharmaceuticals, Inc
0.00%121.8910.7%$270.07m
VRTXVertex Pharmaceuticals Incorporated
0.00%154.701.9%$225.87m
INCYIncyte Corporation
0.00%116.602.5%$209.70m
ALXNAlexion Pharmaceuticals, Inc.
0.00%140.841.9%$178.28m
ILMNIllumina, Inc.
0.00%206.233.5%$141.08m
EXELExelixis, Inc.
0.35%29.126.5%$134.69m
CLVSClovis Oncology, Inc.
0.00%84.5816.5%$131.34m
BLUEBluebird Bio, Inc.
0.14%143.5017.3%$122.17m
SRPTSarepta Therapeutics, Inc.
0.00%50.7316.9%$110.70m
BMRNBioMarin Pharmaceutical Inc.
0.00%94.664.4%$104.77m

Company Profile

pSivida Corp. develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and Tethadur is focused on treatment of chronic diseases of the back of the eye and are also exploring applications outside ophthalmology. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. pSivida was founded by Roger Aston in March 2008 and is headquartered in Waterson, MA.